Loading... Loading... U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Friday. Shares of Smith & Wesson Brands, Inc. SWBI fell sharply in today's pre-market trading after the company reported its fourth-quarter financial results. Smith & Wesson reported quarterly earnings of 45 cents per share, which beat the analyst consensus estimate of 34 cents. Quarterly sales came in at $159.1 million, which beat the analyst consensus estimate of $156.796 million, accordi ...

Core Viewpoint - Abacus Life, Inc. has successfully priced an oversubscribed public offering of 10,000,000 shares at $8.00 per share, aiming to raise approximately $80 million in gross proceeds before expenses [1][2]. Group 1: Offering Details - The public offering includes a 30-day option for underwriters to purchase an additional 1,500,000 shares at the same price [1]. - The offering is expected to close on June 24, 2024, subject to customary closing conditions [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for operations, including the purchase of life settlement policies, working capital, and general corporate purposes, which may involve repayment and refinancing of existing debt [2]. Group 3: Company Overview - Abacus Life, Inc. is a leading alternative asset manager specializing in longevity and actuarial technology, with over $5 billion in face value of life insurance policies purchased since 2004 [5]. - The company operates under the ticker symbol ABL on the Nasdaq Exchange and is recognized as the only public life settlement company [5].

ORLANDO, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. ("Abacus" or the "Company") (NASDAQ:ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced the pricing of its oversubscribed underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $8.00 per share. In connection with the offering, the Company also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of comm ...

As filed with the Securities and Exchange Commission on June 13, 2024. (Exact Name of Registrant as Specified in Its Charter) Registration No. 333-279347 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (State or Other Jurisdiction of Incorporation or Organization) Delaware 6282 85-1210472 (Primary Standard Industrial Classification Code Number) 2101 Park Center Drive, Suite 200 Orlan ...

As filed with the Securities and Exchange Commission on June 13, 2024. Registration No. 333-279347 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 6282 85-1210472 (Primary Standard Industrial Classification Code Number) 2101 Park Center Drive, Suite 200 Orlan ...

As filed with the Securities and Exchange Commission on June 13, 2024. Registration No. 333-279347 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 6282 85-1210472 (Primary Standard Industrial Classification Code Number) 2101 Park Center Drive, Suite 200 Orlan ...

ORLANDO, Fla., June 13, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a pioneering alternative asset manager specializing in longevity and actuarial technology, today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock. In connection with the offering, Abacus intends to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the public offering price. All of the sha ...

Core Viewpoint - Abacus Life, Inc. has initiated an underwritten public offering of 10,000,000 shares of its common stock, with an option for underwriters to purchase an additional 1,500,000 shares [1][2] Group 1: Offering Details - The public offering is subject to general market conditions, and there are no assurances regarding its completion or terms [2] - A registration statement on Form S-1 has been filed with the SEC, but it has not yet become effective [3] Group 2: Use of Proceeds - Abacus plans to use the net proceeds from the offering for operations, including purchasing life settlement policies, supporting its business strategy, working capital, and potentially repaying or refinancing its debt [1] Group 3: Company Overview - Abacus is a leading alternative asset manager specializing in longevity and actuarial technology, with over $5 billion in face value of life insurance policies purchased since 2004 [5] - The company operates three channels: ABL Tech, ABL Wealth, and ABL Longevity Funds, and is the only public life settlement company listed on the Nasdaq Exchange under the ticker symbol ABL [5]

Core Insights - Abacus Life, Inc. led the life settlement industry in 2023 with a 26% market share, paying clients $220 million in life settlement funds, which is over 20% of policy face value on average, significantly higher than competitors [1][2] - The company acquired 640 policies in 2023 with a total face value of nearly $1.1 billion, representing a 31.4% increase from 2022, while the overall industry growth was only 4% [1][3] Company Overview - Abacus is a pioneering alternative asset manager specializing in longevity and actuarial technology, with over $5 billion in face value of policies purchased since its inception in 2004 [3][4] - The company operates through three innovative channels: ABL Tech, ABL Wealth, and ABL Longevity Growth & Income Funds, aiming to democratize the life insurance space [3][4] - Abacus has established a robust origination and portfolio management process supported by a team of over 100 professionals and long-term relationships with 78 institutional partners and 30,000 financial advisors [4] Market Position - The company is recognized as the only public life settlement company, trading on the Nasdaq Exchange under the ticker symbol ABL, and has built a strong reputation with a BBB Accreditation and an A+ rating [3][4]

ORLANDO, Fla., June 06, 2024 (GLOBE NEWSWIRE) --  Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a pioneering alternative asset manager specializing in longevity and actuarial technology, announced today that it led the life settlement industry in funds paid to clients in 2023 with a 26% market share according to The Deal, once again bringing premier value to its clients. For 2023, the Company paid clients $220 million in life settlement funds, corresponding to a 26% market share and equating ...